These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1661 related articles for article (PubMed ID: 25838377)

  • 21. Cancer and the Microbiome-Influence of the Commensal Microbiota on Cancer, Immune Responses, and Immunotherapy.
    Matson V; Chervin CS; Gajewski TF
    Gastroenterology; 2021 Jan; 160(2):600-613. PubMed ID: 33253684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of the microscopic world: Exploring the role and potential of intratumoral microbiota in cancer immunotherapy.
    Zhang L; Yu L
    Medicine (Baltimore); 2024 May; 103(20):e38078. PubMed ID: 38758914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carcinogenesis and therapeutics: the microbiota perspective.
    Tsilimigras MC; Fodor A; Jobin C
    Nat Microbiol; 2017 Feb; 2():17008. PubMed ID: 28225000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Influence of Lung Microbiota on Lung Carcinogenesis, Immunity, and Immunotherapy.
    Ramírez-Labrada AG; Isla D; Artal A; Arias M; Rezusta A; Pardo J; Gálvez EM
    Trends Cancer; 2020 Feb; 6(2):86-97. PubMed ID: 32061309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oncologists tap the microbiome in bid to improve immunotherapy outcomes.
    Mullard A
    Nat Rev Drug Discov; 2018 Mar; 17(3):153-155. PubMed ID: 29449710
    [No Abstract]   [Full Text] [Related]  

  • 26. Gut microbiota contributes towards immunomodulation against cancer: New frontiers in precision cancer therapeutics.
    Inamura K
    Semin Cancer Biol; 2021 May; 70():11-23. PubMed ID: 32580023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.
    Yi M; Jiao D; Qin S; Chu Q; Li A; Wu K
    Integr Cancer Ther; 2019; 18():1534735419876351. PubMed ID: 31517538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gut microbiome in cancer immunotherapy: Current trends, translational challenges and future possibilities.
    Pandey P; Khan F
    Biochim Biophys Acta Gen Subj; 2023 Sep; 1867(9):130401. PubMed ID: 37307905
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methods to Prevent or Treat Refractory Diseases by Focusing on Intestinal Microbes Using LPS and Macrophages.
    Soma G; Inagawa H
    Anticancer Res; 2015 Aug; 35(8):4393-6. PubMed ID: 26168477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular Bioparticulates with Therapeutics for Cancer Immunotherapy.
    Wang C; Wen D; Gu Z
    Bioconjug Chem; 2018 Mar; 29(3):702-708. PubMed ID: 29227626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiota dysbiosis in select human cancers: Evidence of association and causality.
    Chen J; Domingue JC; Sears CL
    Semin Immunol; 2017 Aug; 32():25-34. PubMed ID: 28822617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microbiota as a mediator of cancer progression and therapy.
    Pope JL; Tomkovich S; Yang Y; Jobin C
    Transl Res; 2017 Jan; 179():139-154. PubMed ID: 27554797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the emerging role of the microbiome in cancer immunotherapy.
    Fessler J; Matson V; Gajewski TF
    J Immunother Cancer; 2019 Apr; 7(1):108. PubMed ID: 30995949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bugs in the system: bringing the human microbiome to bear in cancer immunotherapy.
    Strouse C; Mangalam A; Zhang J
    Gut Microbes; 2019; 10(2):109-112. PubMed ID: 30183502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Redrawing therapeutic boundaries: microbiota and cancer.
    Sholl J; Sepich-Poore GD; Knight R; Pradeu T
    Trends Cancer; 2022 Feb; 8(2):87-97. PubMed ID: 34844910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Visualizing microbiome-immune system interplay.
    Siebert JC; Görg C; Palmer B; Lozupone C
    Immunotherapy; 2019 Feb; 11(2):63-67. PubMed ID: 30730269
    [No Abstract]   [Full Text] [Related]  

  • 37. Application of germ-free NOD-scid IL2rg
    Wu C; Shang H; Jiang X; Wang X; Wei H
    Sci China Life Sci; 2021 Apr; 64(4):644-647. PubMed ID: 33644835
    [No Abstract]   [Full Text] [Related]  

  • 38. Metabolic Plasticity of Neutrophils: Relevance to Pathogen Responses and Cancer.
    Rogers T; DeBerardinis RJ
    Trends Cancer; 2021 Aug; 7(8):700-713. PubMed ID: 34023325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy.
    Cogdill AP; Gaudreau PO; Arora R; Gopalakrishnan V; Wargo JA
    Trends Immunol; 2018 Nov; 39(11):900-920. PubMed ID: 30392721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut microbiome and cancer immunotherapy.
    Li W; Deng Y; Chu Q; Zhang P
    Cancer Lett; 2019 Apr; 447():41-47. PubMed ID: 30684593
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 84.